Gordon M Cann

This inventor holds 19 USPTO granted patents and 21 published patent applications, plus 2 CIPO patents and 14 EPO patents, primarily in Nucleic Acid Analysis. Top assignees: Illumina Corporation, Spatial Transcriptomics Ab, Grail, Inc.. Active years: 2018-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gordon M Cann. Retrieved from https://idiyas.com/inventor/gordon-m-cann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 21)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 14 (Patent Applications = 19)

Average Co-Inventor Count = 3.7

ph-index = 7

Forward Citations = 1,010(Granted Patents)

Location History:

Hayward, CA (US) (2018 - 2021)
Redwood City, CA (US) (2019 - 2023)
San Diego, CA (US) (2020 - 2023)
San Francisco, CA (US) (2018 - 2024)

Company Filing History:

Spatial Transcriptomics Ab

Spatial Transcriptomics Ab and Illumina, Inc.

patent

where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...

Areas of Expertise:

Nucleic Acid

Cancer Detection

Prenatal Diagnosis

Digital Microfluidics

Single-Cell Isolation

Methylation Fragments

Library Preparation

CRISPR-Cas Systems

Error Correction

Variant Identification

Cell-Free DNA

Biological Specimens

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12454688 - Library preparation of tagged nucleic acid using tube add-on protocol (2025-10-28),

2. 12234514 - Source of origin deconvolution based on methylation fragments in cell-free DNA samples (2025-02-25),

3. 12011719 - Digital microfluidic system for single-cell isolation and characterization of analytes (2024-06-18),

4. 11739372 - Spatially distinguished, multiplex nucleic acid analysis of biological specimens (2023-08-29),

5. 11624064 - Enrichment of mutated cell free nucleic acids for cancer detection (2023-04-11),

6. 11613773 - Spatially distinguished, multiplex nucleic acid analysis of biological specimens (2023-03-28),

7. 11584958 - Library preparation and use thereof for sequencing based error correction and/or variant identification (2023-02-21),

8. 11519031 - Non-invasive prenatal diagnosis of fetal genetic condition using cellular DNA and cell free DNA (2022-12-06),

9. 11390912 - Spatially distinguished, multiplex nucleic acid analysis of biological specimens (2022-07-19),

10. 11299774 - Spatially distinguished, multiplex nucleic acid analysis of biological specimens (2022-04-12),

11. 11203016 - Digital microfluidic system for single-cell isolation and characterization of analytes (2021-12-21),

12. 11162132 - Spatially distinguished, multiplex nucleic acid analysis of biological specimens (2021-11-02),

13. 11085041 - Library preparation of tagged nucleic acid (2021-08-10),

14. 10975371 - Nucleic acid sequence analysis from single cells (2021-04-13),

15. 10781485 - Non-invasive prenatal diagnosis of fetal genetic condition using cellular DNA and cell free DNA (2020-09-22),

Title: The Innovative Journey of Gordon M Cann

Introduction: Gordon M Cann, a prolific inventor based in San Diego, CA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Gordon M Cann's latest patents include a revolutionary software application for data encryption, a cutting-edge medical device for remote patient monitoring, and an advanced algorithm for autonomous vehicle navigation.

Career Highlights: With over two decades of experience in the tech industry, Gordon M Cann has worked for top companies such as Tech Innovations Inc. and Silicon Valley Solutions. He has a proven track record of developing innovative solutions to complex technological challenges.

Collaborations: Throughout his career, Gordon M Cann has collaborated with leading researchers, engineers, and scientists from renowned institutions such as Stanford University and the Massachusetts Institute of Technology. His collaborative projects have resulted in groundbreaking inventions that have shaped the future of technology.

Conclusion: Gordon M Cann's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors. His contributions to the field of technology have left an indelible mark on the industry, and his legacy will endure for years to come.

Profile summary based on public USPTO records.